Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 25, 2026
DataAggregated Company Financials
Companies7
- 7D-3.3%
- 3M-8.4%
- 1Y-45.3%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.3%, driven by Oxford Nanopore Technologies declining 4.0%. On the other hand hVIVO is actually up 12%. Overall the industry is down 45% in 12 months. As for the next few years, earnings are expected to grow by 51% per annum.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 25 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1126x | -7.6x | 3.9x |
| Mon, 22 Jun 2026 | UK£1.4b | UK£323.0m | -UK£166,018,254.00 | 1291.9x | -8.2x | 4.2x |
| Wed, 20 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.3x | 4.4x |
| Fri, 17 Apr 2026 | UK£1.4b | UK£323.0m | -UK£156,192,254.00 | 12.1x | -9x | 4.3x |
| Sun, 15 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.3x | -8.4x | 4.2x |
| Tue, 10 Feb 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 7.8x | -10x | 5.3x |
| Thu, 08 Jan 2026 | UK£1.6b | UK£304.6m | -UK£159,441,254.00 | 8x | -10x | 5.2x |
| Sat, 06 Dec 2025 | UK£1.4b | UK£303.9m | -UK£162,910,254.00 | 6.4x | -8.6x | 4.6x |
| Mon, 03 Nov 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.5x | -9.5x | 5.1x |
| Wed, 01 Oct 2025 | UK£1.7b | UK£304.0m | -UK£163,375,352.00 | 10x | -10.4x | 5.6x |
| Fri, 29 Aug 2025 | UK£2.1b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -12.8x | 7x |
| Sun, 27 Jul 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -13.9x | 7.7x |
| Tue, 24 Jun 2025 | UK£1.5b | UK£319.4m | -UK£190,835,191.60 | 6.4x | -8.1x | 4.8x |
| Thu, 22 May 2025 | UK£1.6b | UK£313.6m | -UK£192,232,110.60 | 11x | -8.6x | 5.2x |
| Sat, 19 Apr 2025 | UK£1.6b | UK£314.9m | -UK£185,639,007.85 | 6.3x | -8.5x | 5x |
| Mon, 17 Mar 2025 | UK£1.5b | UK£315.6m | -UK£186,194,740.85 | 6.3x | -7.9x | 4.7x |
| Wed, 12 Feb 2025 | UK£1.9b | UK£307.0m | -UK£195,613,261.44 | 7.2x | -9.6x | 6.1x |
| Fri, 10 Jan 2025 | UK£1.9b | UK£307.4m | -UK£195,896,290.56 | 7.1x | -9.9x | 6.3x |
| Sun, 08 Dec 2024 | UK£2.0b | UK£306.1m | -UK£194,895,325.20 | 8.2x | -10.3x | 6.5x |
| Tue, 05 Nov 2024 | UK£1.9b | UK£304.7m | -UK£192,583,666.30 | 11.1x | -10.1x | 6.4x |
| Thu, 03 Oct 2024 | UK£2.1b | UK£303.9m | -UK£191,909,787.70 | 10.9x | -11.1x | 7x |
| Sat, 31 Aug 2024 | UK£1.8b | UK£295.7m | -UK£188,377,847.70 | 12.4x | -9.5x | 6.1x |
| Mon, 29 Jul 2024 | UK£1.9b | UK£295.4m | -UK£189,801,674.25 | 12.6x | -9.8x | 6.3x |
| Wed, 26 Jun 2024 | UK£1.4b | UK£295.9m | -UK£190,214,150.01 | 11.4x | -7.5x | 4.8x |
| Fri, 24 May 2024 | UK£1.7b | UK£295.7m | -UK£189,922,642.59 | 11.2x | -8.8x | 5.6x |
| Sun, 21 Apr 2024 | UK£1.5b | UK£318.0m | -UK£178,762,280.21 | 11.3x | -8.1x | 4.6x |
| Tue, 19 Mar 2024 | UK£1.9b | UK£295.6m | -UK£212,977,254.25 | 7176.9x | -8.8x | 6.3x |
| Thu, 15 Feb 2024 | UK£2.1b | UK£286.0m | -UK£189,459,994.96 | 6999.9x | -11.2x | 7.4x |
| Sat, 13 Jan 2024 | UK£2.9b | UK£449.9m | -UK£173,931,009.00 | 67.7x | -16.9x | 6.5x |
| Mon, 11 Dec 2023 | UK£3.0b | UK£453.0m | -UK£170,803,824.00 | 47.2x | -17.3x | 6.5x |
| Wed, 08 Nov 2023 | UK£3.1b | UK£458.3m | -UK£165,352,907.00 | 47.2x | -18.9x | 6.8x |
| Fri, 06 Oct 2023 | UK£2.9b | UK£448.9m | -UK£169,314,935.00 | 60x | -17.4x | 6.6x |
| Sun, 03 Sep 2023 | UK£3.1b | UK£476.5m | -UK£126,789,628.00 | 70.6x | -24.6x | 6.5x |
| Tue, 01 Aug 2023 | UK£3.4b | UK£476.2m | -UK£124,495,619.00 | 69.6x | -27.3x | 7.1x |
Price to Earnings Ratio
-27.3x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 1.20% | |
| Healthcare | 0.051% | |
| Life Sciences | -3.33% | |
| Clinical Research and Equipment | -3.33% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| HVO hVIVO | UK£0.075 | 11.9% +UK£5.5m | -25.0% | PS1x | |
| FAB Fusion Antibodies | UK£0.11 | 4.4% +UK£562.6k | 22.9% | PS8.4x |